Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27733243

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 Nov
First author
Sharma P

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Nov;17(11):1475-1477. doi: 10.1016/S1470-2045(16)30497-1.
    note
    Source null
    related pmid
    27733242
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2019 Feb;20(2):e71. doi: 10.1016/S1470-2045(19)30014-2.
    note
    Source null
    related pmid
    30712805
    relationship
    Erratum in

Authors and identifiers

  1. name
    Sharma P
    type
    Author
  2. name
    Callahan MK
    type
    Author
  3. name
    Bono P
    type
    Author
  4. name
    Kim J
    type
    Author
  5. name
    Spiliopoulou P
    type
    Author
  6. name
    Calvo E
    type
    Author
  7. name
    Pillai RN
    type
    Author
  8. name
    Ott PA
    type
    Author
  9. name
    de Braud F
    type
    Author
  10. name
    Morse M
    type
    Author
  11. name
    Le DT
    type
    Author
  12. name
    Jaeger D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sharma P
    type
    Author
  2. name
    Callahan MK
    type
    Author
  3. name
    Bono P
    type
    Author
  4. name
    Kim J
    type
    Author
  5. name
    Spiliopoulou P
    type
    Author
  6. name
    Calvo E
    type
    Author
  7. name
    Pillai RN
    type
    Author
  8. name
    Ott PA
    type
    Author
  9. name
    de Braud F
    type
    Author
  10. name
    Morse M
    type
    Author
  11. name
    Le DT
    type
    Author
  12. name
    Jaeger D
    type
    Author
bibliography ids
  1. nci-bib-faa8edd4b8c169ac131312ca
book metadata
content sha256
c0a8c2771198fcf43a635b0ba9dbdd89d831315b5e3312ced13aca7ab1004ea5
document type
citation
dois
  1. 10.1016/S1470-2045(16)30496-X
electronic publication date
display
2016 Oct 9
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27733243
immutable id
pubmed:27733243@c0a8c2771198fcf43a635b0ba9dbdd89d831315b5e3312ced13aca7ab1004ea5
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1590-1598
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Nov;17(11):1475-1477. doi: 10.1016/S1470-2045(16)30497-1.
    note
    Source null
    related pmid
    27733242
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2019 Feb;20(2):e71. doi: 10.1016/S1470-2045(19)30014-2.
    note
    Source null
    related pmid
    30712805
    relationship
    Erratum in
outcomes validated
false
pmid
27733243
provenance
batch id
d649bcb2d98dbbacd53c
provider
NCBI PubMed ESummary
record sha256
4ee7ffd344c45eaff28c0ddd005c50b290b439e535ff3200f2bfd2acc185b917
response sha256
26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
retrieved at
2026-09-09T23:47:20.761544+00:00
publication date
display
2016 Nov
precision
month
year
2016
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27733243/
title
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.

Preserved source evidence · Not medical advice